In addition to these risk factors, we also recently demonstrated that genetic variability in specific genes (e.g., MUC2, NFKB1 and CD14) is associated with the progression to gastric cancer from precursor lesions [10]. This evidence concerns the gene MUC2 and gastric cancer.